More importantly, the expression of epidermal growth factor receptor (EGFR) could be represented as a negative feedback that is controlled by COX-2 in patients suffering from lung cancer by mediating the activation of several signaling cascades (Prado et al., 2010). The gene discussed is EGFR; the disease is lung cancer.